🦠 microbiology

Aspartate aminotransferase is required for Salmonella expansion in the inflamed gut via TCA anaplerosis

This study demonstrates that the aspartate aminotransferase AspC is essential for *Salmonella* Typhimurium to expand in the inflamed gut by enabling the catabolism of aspartate to fuel the TCA cycle, a requirement that is specific to gut colonization and not systemic infection.

Original authors: Shealy, N. G., Baltagulov, M., Avalos, H. F., Olivas, J., Jones, K. M., Byndloss, M. X.

Published 2026-02-26

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Shealy, N. G., Baltagulov, M., Avalos, H. F., Olivas, J., Jones, K. M., Byndloss, M. X.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine the human gut as a bustling, crowded city. Normally, the "local residents" (our friendly gut bacteria) have already claimed all the best real estate and eaten all the available food. When a bad guy like Salmonella tries to move in, it finds a food desert. It's like trying to start a restaurant in a neighborhood where every grocery store is already closed and the locals have eaten all the ingredients.

However, when the city gets into a fight (an infection causing inflammation), the rules change. The local residents get wiped out, and suddenly, a specific type of food—aspartate (a building block for proteins)—becomes abundant. Salmonella is smart; it knows how to grab this food and use it to power its engines to grow and spread.

But here is the twist: Salmonella doesn't just eat aspartate; it needs a special chef to turn that food into fuel. That chef is an enzyme called AspC.

The Story of the Missing Chef

This paper is about what happens when Salmonella loses this chef (AspC). The researchers, led by Dr. Mariana Byndloss, wanted to see if the bacteria could survive without it.

1. The "City" vs. The "Countryside" (Gut vs. Systemic)
The team tested the bacteria in two different scenarios:

The Countryside (Systemic Infection): They injected the bacteria directly into the bloodstream (the liver and spleen). Here, the bacteria didn't care if they had the AspC chef or not. They grew just fine. It's like having a backup generator that works perfectly in the open country.
The City (The Inflamed Gut): When they let the bacteria infect the gut naturally (through the mouth), things went wrong. At first, the bacteria without the chef (the mutant) looked okay. But as the infection progressed and the gut became more inflamed, the mutant bacteria started to fail miserably. They couldn't keep up with the wild-type bacteria. By day 9, the mutant bacteria were nearly wiped out.

The Lesson: AspC is only essential when the bacteria are fighting for survival in the messy, competitive environment of the inflamed gut.

2. The Fuel Problem (The TCA Cycle)
Why did the mutant fail in the gut?
Think of the bacteria's energy production as a car engine (called the TCA cycle).

The Problem: In the inflamed gut, the bacteria switch to a special mode of running their engine called "anaerobic respiration" (running without oxygen, using other chemicals like nitrate). To keep this engine running, they need to constantly refill a specific part of the engine called Oxaloacetate.
The Chef's Job: The AspC chef's job is to take the available aspartate and convert it into Oxaloacetate to keep the engine full.
The Breakdown: Without AspC, the bacteria can't make Oxaloacetate. Their engine sputters and stalls. They have plenty of food (aspartate), but they can't turn it into the specific fuel their engine needs to run in the gut.

3. The Rescue Mission
The researchers proved this by playing with the fuel tank:

Adding the missing part: When they added Oxaloacetate (the missing fuel) directly to the bacteria, the mutant bacteria suddenly started growing again!
The "Avirulent" Test: They even tested bacteria that couldn't cause inflammation (they couldn't break into the city walls). Surprisingly, these bacteria still needed AspC to survive in the gut. This suggests that the need for this chef isn't just about causing disease; it's about the fundamental way the bacteria eats and breathes in that specific environment.

The Big Picture Analogy

Imagine Salmonella is a delivery truck trying to make a delivery in a city during a blackout (inflammation).

The Fuel: The city has a massive supply of Aspartate (gasoline).
The Engine: The truck needs to run on a special Oxaloacetate fuel mix to work in the dark.
The Chef (AspC): This is the mechanic who knows how to mix the Aspartate gasoline into the Oxaloacetate fuel.
The Result: If the truck has the mechanic, it drives fast and delivers its package (infection spreads). If the truck loses the mechanic, it sits in the driveway with a full tank of gas but can't start the engine. It gets left behind.

Why Does This Matter?

This discovery is a "Aha!" moment for scientists. It tells us that Salmonella has a very specific weakness: it cannot survive in an inflamed gut without its AspC chef.

While the bacteria can survive in other parts of the body without this enzyme, the gut is a unique battlefield where this specific metabolic pathway is the key to victory. This opens the door for new treatments. Instead of trying to kill the bacteria with antibiotics (which can also hurt our good bacteria), we might be able to develop drugs that specifically block the AspC chef. If we do that, the Salmonella bacteria will starve in the gut, unable to expand, and the infection could be stopped before it gets serious.

In short: Salmonella is a tough customer, but in the inflamed gut, it's like a car with a missing spark plug. Take away its ability to convert aspartate into fuel, and it simply won't go.

1. Problem Statement

Nutrient Scarcity: The mammalian gut is a nutrient-scarce environment for enteric pathogens like Salmonella enterica serovar Typhimurium (S. Tm) due to competition from the resident microbiota.
Aspartate Dynamics: Previous research established that S. Tm utilizes aspartate as a nutrient source during gut inflammation (via AspA for fumarate respiration). However, it was unknown how S. Tm copes with aspartate starvation or how it utilizes aspartate for metabolic maintenance during the early stages of colonization and expansion.
The Knowledge Gap: While the aspartate aminotransferase enzyme AspC (encoded by aspC) is known to interconvert aspartate and oxaloacetate (a TCA cycle intermediate), its specific role in S. Tm pathogenesis, particularly regarding the distinction between systemic survival and gut colonization, remained undefined.

2. Methodology

The study employed a combination of in vivo murine infection models and in vitro metabolic assays to dissect the role of AspC.

Strain Construction:
- Generated an isogenic S. Tm $\Delta$ aspC mutant.
- Created double mutants lacking Type III Secretion Systems (T3SS) ( $\Delta$ invA $\Delta$ spiB) to test inflammation dependence.
- Generated TCA cycle enzyme mutants ( $\Delta$ gltA, $\Delta$ sdhA, $\Delta$ frdABCD) to map metabolic dependencies.
- Created complemented strains and strains with TCA intermediate supplementation.
In Vivo Models (CBA/J Mice):
- Systemic Infection: Intraperitoneal (IP) injection of a 1:1 competitive mixture of Wild Type (WT) and $\Delta$ aspC to assess fitness in the liver, spleen, and peritoneal cavity.
- Gastrointestinal Infection: Oral gavage (fecal-oral route) with competitive mixtures or single strains to assess colonization in the cecum, colon, and feces over 10 days.
In Vitro Assays:
- Growth Kinetics: Anaerobic growth in NCE minimal media with various carbon sources (glucose, glycerol) and electron acceptors (nitrate, tetrathionate) mimicking inflamed vs. healthy gut conditions.
- Competition Assays: Co-culture of WT and $\Delta$ aspC under anaerobic respiration conditions with and without TCA intermediates (fumarate, succinate, oxaloacetate).
- Gene Expression: qPCR analysis of aspC, dcuA (aspartate importer), aspA, and biosynthetic genes (pyrB, lysC) under anaerobic respiration conditions.

3. Key Results

A. Site-Specific Requirement for AspC

Systemic Sites: In IP infections, the $\Delta$ aspC mutant showed no competitive defect compared to WT in the liver, spleen, or peritoneal fluid over 3–5 days. AspC is dispensable for systemic survival in this model.
Gut Lumen: In oral infections, $\Delta$ aspC showed no defect at day 1 post-infection (p.i.). However, a significant colonization defect emerged by day 5 p.i., increasing to ~100-fold by day 9 p.i. in feces and cecal/colon contents.
Inflammation Dependence: The defect was specific to the gut lumen expansion phase. Interestingly, in avirulent strains ( $\Delta$ invA $\Delta$ spiB) that cannot induce inflammation, the $\Delta$ aspC defect was actually more pronounced early on, suggesting AspC is critical for expansion regardless of the specific virulence program, but the defect manifests differently over time.

B. Metabolic Mechanism: TCA Anaplerosis

Respiration Dependency: The growth defect of $\Delta$ aspC was observed specifically during anaerobic respiration using inflammation-derived electron acceptors (nitrate, tetrathionate) and glycerol as a carbon source. It was not observed in glucose-rich or aerobic conditions.
Aspartate Limitation: The defect was exacerbated under low aspartate conditions (0–0.1 mM) but rescued by high aspartate supplementation (10 mM).
TCA Cycle Connection:
- Supplementation with TCA intermediates (fumarate, succinate, or oxaloacetate) during anaerobic respiration rescued the fitness defect of $\Delta$ aspC.
- Genetic deletion of gltA (citrate synthase) or sdhA (succinate dehydrogenase)—key enzymes in the oxidative TCA cycle—abrogated the fitness defect of $\Delta$ *aspC$.
- Deletion of frdABCD (fumarate reductase, involved in the reductive branched-chain TCA) did not abrogate the defect, indicating AspC is specifically required for the oxidative TCA cycle.

C. Gene Expression and Biosynthesis

Transcriptomic analysis showed that $\Delta$ aspC upregulated the aspartate importer (dcuA) and genes for pyrimidine and lysine synthesis (pyrB, lysC), indicating a cellular stress response to aspartate limitation.
However, these biosynthetic pathways remained functional, suggesting the primary defect is not the inability to synthesize aspartate-derived biomolecules, but rather a failure in energy generation via the TCA cycle.

4. Key Contributions

Dissected Site-Specificity: Demonstrated that AspC is essential for S. Tm expansion in the inflamed gut lumen but dispensable for systemic survival in CBA/J mice, contrasting with findings in S. aureus where AspC is vital for systemic survival.
Defined the Metabolic Role: Established that AspC's critical function during gut infection is anaplerosis—specifically, converting aspartate to oxaloacetate to fuel the oxidative TCA cycle during anaerobic respiration.
Mechanism of Expansion: Clarified that S. Tm relies on AspC not just for aspartate scavenging (via AspA) but for maintaining TCA cycle flux to generate energy (ATP) when utilizing inflammation-derived electron acceptors (nitrate/tetrathionate).
Virulence Independence: Showed that the requirement for AspC is distinct from the T3SS-mediated invasion machinery, as the metabolic defect persists even in avirulent backgrounds.

5. Significance

Pathogenesis Insight: This study reveals a critical metabolic vulnerability in S. Tm. The pathogen must maintain a functional oxidative TCA cycle to expand in the inflamed gut, relying on AspC to replenish oxaloacetate from aspartate.
Therapeutic Potential: Targeting AspC or the specific anaplerotic pathway could selectively inhibit S. Tm expansion in the gut without affecting systemic survival mechanisms, potentially offering a strategy to reduce gastroenteritis severity.
Metabolic Adaptation: Highlights how pathogens rewire central carbon metabolism (switching from reductive to oxidative TCA cycles) in response to the specific nutrient and redox landscape of the inflamed host gut.

Conclusion: The paper concludes that AspC is a critical enzyme for S. Tm pathogenesis in the gut, acting as a metabolic bridge that allows the bacterium to utilize aspartate to fuel the oxidative TCA cycle, thereby supporting energy generation and competitive expansion during intestinal inflammation.